Sign in Subscribe
Scientists

Systemic Lupus Erythematosus Drains Wallets and Productivity

Strategic Insights

— 1 min read

Recent research published in the Arthritis and Rheumatism journal has shed light on the significant financial burden of systemic lupus erythematosus (SLE) on individuals in the United States. The University of California, San Francisco Lupus Outcomes Study revealed that SLE not only incurs substantial direct healthcare costs but also impacts work productivity, resulting in substantial productivity costs. This study emphasizes the critical need for effective management and treatment strategies to mitigate these consequences.

Key Takeaways:

  • The mean annual direct healthcare cost for individuals with SLE was $12,643 (2004 US dollars).
  • Productivity costs for employed individuals of working age (≥18 and ≤65) were substantial, with 9,341 hours lost per year.
  • Both direct healthcare costs and productivity costs were significant contributors to the total costs associated with SLE.
  • The researchers highlighted the importance of considering both direct healthcare costs and productivity costs in estimating the overall economic burden of SLE.
  • Panopalis and colleagues' study has provided valuable insights into the economic implications of SLE, emphasizing the need for cost-effective treatment and management strategies.

Statistics:

  • Mean annual direct healthcare cost: $12,643 (2004 US dollars)
  • Mean annual productivity cost: 9,341 hours lost per year
  • Total population of participants: likely in the thousands, as the study used data from the University of California, San Francisco Lupus Outcomes Study.
  • Productivity cost estimates were compared with normal US population data to highlight the significance of this impact.

Sources:

  • Panopalis, P., and colleagues. (2008). Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis and Rheumatism, 59(12), 1788-1795.
  • University of California, San Francisco Lupus Outcomes Study.
  • www.wiley.com (publisher of Arthritis and Rheumatism).
  • Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.

Read more